BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Singh S, Singh PP. Statin a day keeps cancer at bay. World J Clin Oncol 2013; 4(2): 43-46 [PMID: 23696961 DOI: 10.5306/wjco.v4.i2.43]
URL: https://www.wjgnet.com/2218-4333/full/v4/i2/43.htm
Number Citing Articles
Mary L. Hardy, Karen Duvall. Multivitamin/multimineral supplements for cancer prevention: implications for primary care practicePostgraduate Medicine 2015; 127(1): 107 doi: 10.1080/00325481.2015.993284
Rafael Simó, Oleguer Plana-Ripoll, Diana Puente, Rosa Morros, Xavier Mundet, Luz M. Vilca, Cristina Hernández, Inmaculada Fuentes, Adriana Procupet, Josep M. Tabernero, Concepción Violán, Amar Abderrahmani. Impact of Glucose-Lowering Agents on the Risk of Cancer in Type 2 Diabetic Patients. The Barcelona Case-Control StudyPLoS ONE 2013; 8(11): e79968 doi: 10.1371/journal.pone.0079968
Baoge Qu, Hao Qu. The Influence of Statins on Risk and Patient Survival in Colorectal CancerJournal of Clinical Gastroenterology 2019; 53(9): 699 doi: 10.1097/MCG.0000000000000844
Tina Fransgaard, Lau Caspar Thygesen, Ismail Gögenur. Statin use is not associated with improved 30-day survival in patients undergoing surgery for colorectal cancerInternational Journal of Colorectal Disease 2018; 33(2): 199 doi: 10.1007/s00384-017-2947-9
Behzad Yeganeh, Emilia Wiechec, Sudharsana R. Ande, Pawan Sharma, Adel Rezaei Moghadam, Martin Post, Darren H. Freed, Mohammad Hashemi, Shahla Shojaei, Amir A. Zeki, Saeid Ghavami. Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary diseasePharmacology & Therapeutics 2014; 143(1): 87 doi: 10.1016/j.pharmthera.2014.02.007
Jing-Yang Huang, Zhi-Hong Jian, Oswald Ndi Nfor, Kai-Ming Jhang, Wen-Yuan Ku, Pei-Chieh Ko, Shiou-Rung Jan, Chien-Chang Ho, Chia-Chi Lung, Hui-Hsien Pan, Yu-Chiu Liang, Yung-Po Liaw, Yuanpu Peter Di. The Impact of Coexisting Asthma, Chronic Obstructive Pulmonary Disease and Tuberculosis on Survival in Patients with Lung Squamous Cell CarcinomaPLOS ONE 2015; 10(7): e0133367 doi: 10.1371/journal.pone.0133367
I. Vasiliadis, G. Kolovou, D. P. Mikhailidis. Cardiotoxicity and Cancer TherapyAngiology 2014; 65(5): 369 doi: 10.1177/0003319713498298
Pilar Mazón Ramos. Del concepto de estatinas de alta potencia a los efectos extralipídicos de las estatinasRevista Española de Cardiología Suplementos 2015; 15: 22 doi: 10.1016/S1131-3587(15)70121-4
Tingting Wang, Serena Seah, Xinyi Loh, Ching-Wan Chan, Mikael Hartman, Boon-Cher Goh, Soo-Chin Lee. Simvastatin-induced breast cancer cell death and deactivation of PI3K/Akt and MAPK/ERK signalling are reversed by metabolic products of the mevalonate pathwayOncotarget 2016; 7(3): 2532 doi: 10.18632/oncotarget.6304
Patricia A.J. Muller, Karen H. Vousden. Mutant p53 in Cancer: New Functions and Therapeutic OpportunitiesCancer Cell 2014; 25(3): 304 doi: 10.1016/j.ccr.2014.01.021
Yong Zhang, Weijia Kong, Jiandong Jiang. Prevention and treatment of cancer targeting chronic inflammation: research progress, potential agents, clinical studies and mechanismsScience China Life Sciences 2017; 60(6): 601 doi: 10.1007/s11427-017-9047-4